Is Risk Stratification for Bleeding and Ischemic Events Still Useful When De-Escalating to Ticagrelor Monotherapy?

Puja B. Parikh; Tullio Palmerini

doi:10.1016/j.jacc.2023.06.010

Is Risk Stratification for Bleeding and Ischemic Events Still Useful When De-Escalating to Ticagrelor Monotherapy?

Puja B. Parikh
, Tullio Palmerini

Department of Medicine - Division of Cardiology

IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Bologna

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	701-703
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	82
Issue number	8
DOIs	https://doi.org/10.1016/j.jacc.2023.06.010
State	Published - Aug 22 2023

Keywords

aspirin
bleeding
dual antiplatelet therapy
monotherapy
risk
ticagrelor

Access to Document

10.1016/j.jacc.2023.06.010

Cite this

@article{ced7d16ed78c410db8d236ab6f486a34,

title = "Is Risk Stratification for Bleeding and Ischemic Events Still Useful When De-Escalating to Ticagrelor Monotherapy?",

keywords = "aspirin, bleeding, dual antiplatelet therapy, monotherapy, risk, ticagrelor",

author = "Parikh, \{Puja B.\} and Tullio Palmerini",

year = "2023",

month = aug,

day = "22",

doi = "10.1016/j.jacc.2023.06.010",

language = "English",

volume = "82",

pages = "701--703",

journal = "Journal of the American College of Cardiology",